Adrenoleukodystrophy [clinicaltrials_resource:efe245d2a6f3b003edf11d0aeacd835d]
clinicaltrials:NCT00004418Study of Bile Acids in Patients With Peroxisomal Disorders [clinicaltrials:NCT00004442]Randomized Study of Beta Interferon and Thalidomide in Patients With Adrenoleukodystrophy [clinicaltrials:NCT00004450]Study of Pulmonary Complications in Pediatric Patients With Storage Disorders Undergoing Allogeneic Hematopoietic Stem Cell Transplantation [clinicaltrials:NCT00005900]clinicaltrials:NCT00007020clinicaltrials:NCT00176904Clinical Study and Gene Mutation Analysis of Adrenoleukodystrophy in Taiwanese Children [clinicaltrials:NCT00278044]clinicaltrials:NCT00383448clinicaltrials:NCT00545597clinicaltrials:NCT01586455clinicaltrials:NCT02171104clinicaltrials:NCT02254863
condition [clinicaltrials_vocabulary:condition]
clinicaltrials:NCT00004418Study of Bile Acids in Patients With Peroxisomal Disorders [clinicaltrials:NCT00004442]Randomized Study of Beta Interferon and Thalidomide in Patients With Adrenoleukodystrophy [clinicaltrials:NCT00004450]Study of Pulmonary Complications in Pediatric Patients With Storage Disorders Undergoing Allogeneic Hematopoietic Stem Cell Transplantation [clinicaltrials:NCT00005900]clinicaltrials:NCT00007020clinicaltrials:NCT00176904Clinical Study and Gene Mutation Analysis of Adrenoleukodystrophy in Taiwanese Children [clinicaltrials:NCT00278044]clinicaltrials:NCT00383448clinicaltrials:NCT00545597clinicaltrials:NCT01043640The Effect of Bezafibrate on the Level of Very Long Chain Fatty Acids (VLCFA) in X-linked Adrenoleukodystrophy (X-ALD) [clinicaltrials:NCT01165060]Phase I/II Pilot Study of Mixed Chimerism to Treat Inherited Metabolic Disorders [clinicaltrials:NCT01372228]A Clinical Trial for AMN: Validation of Biomarkers of Oxidative Stress, Efficacy and Safety of a Mixture of Antioxidants [clinicaltrials:NCT01495260]clinicaltrials:NCT01586455Exercise Study of Function and Pathology for Women With X-linked Adrenoleukodystrophy [clinicaltrials:NCT01594853]clinicaltrials:NCT01787578A Phase 2/3 Study of the Efficacy and Safety of Hematopoietic Stem Cells Transduced With Lenti-D Lentiviral Vector for the Treatment of Childhood Cerebral Adrenoleukodystrophy (CCALD) [clinicaltrials:NCT01896102]clinicaltrials:NCT02171104Observational Safety and Efficacy Study of Allo-HSCT to Treat Childhood Cerebral Adrenoleukodystrophy [clinicaltrials:NCT02204904]Expanded Access for Lorenzo's Oil (GTO/GTE) in Adrenoleukodystrophy [clinicaltrials:NCT02233257]clinicaltrials:NCT02254863MT2014-14 IT-MSC for Advanced Cerebral Adrenoleukodystrophy (cALD) [clinicaltrials:NCT02410239]
condition browse [clinicaltrials_vocabulary:condition-browse]
clinicaltrials:NCT00004418Study of Bile Acids in Patients With Peroxisomal Disorders [clinicaltrials:NCT00004442]Randomized Study of Beta Interferon and Thalidomide in Patients With Adrenoleukodystrophy [clinicaltrials:NCT00004450]Study of Pulmonary Complications in Pediatric Patients With Storage Disorders Undergoing Allogeneic Hematopoietic Stem Cell Transplantation [clinicaltrials:NCT00005900]clinicaltrials:NCT00007020clinicaltrials:NCT00176904Clinical Study and Gene Mutation Analysis of Adrenoleukodystrophy in Taiwanese Children [clinicaltrials:NCT00278044]clinicaltrials:NCT00383448clinicaltrials:NCT00545597clinicaltrials:NCT01043640The Effect of Bezafibrate on the Level of Very Long Chain Fatty Acids (VLCFA) in X-linked Adrenoleukodystrophy (X-ALD) [clinicaltrials:NCT01165060]Phase I/II Pilot Study of Mixed Chimerism to Treat Inherited Metabolic Disorders [clinicaltrials:NCT01372228]A Clinical Trial for AMN: Validation of Biomarkers of Oxidative Stress, Efficacy and Safety of a Mixture of Antioxidants [clinicaltrials:NCT01495260]clinicaltrials:NCT01586455Exercise Study of Function and Pathology for Women With X-linked Adrenoleukodystrophy [clinicaltrials:NCT01594853]clinicaltrials:NCT01787578A Phase 2/3 Study of the Efficacy and Safety of Hematopoietic Stem Cells Transduced With Lenti-D Lentiviral Vector for the Treatment of Childhood Cerebral Adrenoleukodystrophy (CCALD) [clinicaltrials:NCT01896102]clinicaltrials:NCT02171104Observational Safety and Efficacy Study of Allo-HSCT to Treat Childhood Cerebral Adrenoleukodystrophy [clinicaltrials:NCT02204904]Expanded Access for Lorenzo's Oil (GTO/GTE) in Adrenoleukodystrophy [clinicaltrials:NCT02233257]clinicaltrials:NCT02254863MT2014-14 IT-MSC for Advanced Cerebral Adrenoleukodystrophy (cALD) [clinicaltrials:NCT02410239]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Adrenoleukodystrophy [clinicaltrials_resource:efe245d2a6f3b003edf11d0aeacd835d]
Bio2RDF identifier
efe245d2a6f3b003edf11d0aeacd835d
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:efe245d2a6f3b003edf11d0aeacd835d
identifier
clinicaltrials_resource:efe245d2a6f3b003edf11d0aeacd835d
title
Adrenoleukodystrophy
@en
type
label
Adrenoleukodystrophy [clinicaltrials_resource:efe245d2a6f3b003edf11d0aeacd835d]
@en
Adrenoleukodystrophy